BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 95945)

  • 1. Bacterial sensitivity to minocycline (minocin) of clinical isolations.
    Wamola IA; Slack RC
    East Afr Med J; 1977 Nov; 54(11):658-60. PubMed ID: 95945
    [No Abstract]   [Full Text] [Related]  

  • 2. [Doxycycline and minocycline HC1; a comparative study].
    Verwey H; Driessen OM; Michel MF
    Ned Tijdschr Geneeskd; 1977 Jan; 121(2):54-8. PubMed ID: 321980
    [No Abstract]   [Full Text] [Related]  

  • 3. [Synergism of ciprofloxacin with beta-lactam antibiotics, gentamicin, minocycline and pipemidic acid].
    Dickgiesser N; in der Stroth S; Wundt W
    Infection; 1986; 14(2):82-5. PubMed ID: 2940188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic resistance in general practice.
    Hammond L
    Aust Fam Physician; 1990 May; 19(5):723-4, 727, 730-1. PubMed ID: 2111984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent status of bacterial sensitivities to various antibiotics.
    Fearn J; Ahmed SI
    J Pak Med Assoc; 1976 Nov; 26(11):220-3. PubMed ID: 829148
    [No Abstract]   [Full Text] [Related]  

  • 6. [Tetracyclines: bacteriostatic or bactericidal drugs? In vitro studies with rolitetracycline, minocycline and doxycycline (author's transl)].
    Daschner F
    Zentralbl Bakteriol Orig A; 1977 Dec; 239(4):527-34. PubMed ID: 345688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibacterial activity of a new thiatetracycline antibiotic, thiacycline, in comparison with tetracycline, doxycycline and minocycline.
    Russell AD; Ahonkhai I
    J Antimicrob Chemother; 1982 Jun; 9(6):445-9. PubMed ID: 7050073
    [No Abstract]   [Full Text] [Related]  

  • 8. [Antibacterial activity of minocycline alone and associated with other antibiotics (author's transl)].
    Joly BH; Sirot JL; Cluzel MG
    Pathol Biol (Paris); 1976 Apr; 24(4):257-64. PubMed ID: 778758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [In vitro antibacterial activity of doxycycline and minocycline (author's transl)].
    Yokozawa M; Nakagawa K
    Jpn J Antibiot; 1975 Aug; 28(4):600-4. PubMed ID: 1099270
    [No Abstract]   [Full Text] [Related]  

  • 10. Bactericidal effect of combinations of cephalosporins with tobramycin on clinical isolates of Escherichia coli, Klebsiella and Staphylococcus aureus.
    Wagenvoort JH; Brus-Weijer L; Michel MF
    Arzneimittelforschung; 1986 Sep; 36(9):1301-2. PubMed ID: 3539124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple drug-resistant Staphylococcus aureus with resistance to oxytetracycline and minocycline, an example for the distribution of a multiresistant strain-clone.
    Witte W; Dünnhaupt K
    J Hyg Epidemiol Microbiol Immunol; 1982; 26(1):49-56. PubMed ID: 7086123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of tigecycline against clinical isolates of Staphylococcus aureus and extended-spectrum beta-lactamase-producing Escherichia coli in Granada, Spain.
    Sorlózano A; Gutiérrez J; Salmerón A; Luna JD; Martínez-Checa F; Román J; Piédrola G
    Int J Antimicrob Agents; 2006 Dec; 28(6):532-6. PubMed ID: 17045785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Activity in vitro and pharmacokinetics of minocycline (author's transl)].
    Simon C; Malerczyk V; Preuss I; Schmidt K; Grahmann H
    Arzneimittelforschung; 1976 Apr; 26(4):556-60. PubMed ID: 782466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laboratory and clinical studies of cefaclor in Japan.
    Fujii R
    Postgrad Med J; 1979; 55 Suppl 4():88-92. PubMed ID: 398486
    [No Abstract]   [Full Text] [Related]  

  • 15. [2 mechanisms of tetracycline resistance in bacteria].
    Plakunov VK; Myl'nikova SI
    Antibiotiki; 1976 Oct; 21(10):872-6. PubMed ID: 793507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimum inhibitory concentrations of penicillin and minocycline for 300 isolates of N. gonorrhoeae.
    Shahidullah M; Greaves PW
    Br J Vener Dis; 1975 Aug; 51(4):265-6. PubMed ID: 808250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Sensitivity range of gram-negative microorganisms and mycoplasms to minocycline in vitro].
    Schmid E; Price P; Krech U
    Arzneimittelforschung; 1974 Sep; 24(9):1256-8. PubMed ID: 4373015
    [No Abstract]   [Full Text] [Related]  

  • 18. In vitro activities of tigecycline (GAR-936) against multidrug-resistant Staphylococcus aureus and Streptococcus pneumoniae.
    Kitzis MD; Ly A; Goldstein FW
    Antimicrob Agents Chemother; 2004 Jan; 48(1):366-7. PubMed ID: 14693571
    [No Abstract]   [Full Text] [Related]  

  • 19. ["In vitro" and "in vivo" antibacterial activity of a new synthetic antibiotic cinoxacin].
    Ravagnan G; Piccolomini R
    Boll Soc Ital Biol Sper; 1979 Jul; 55(14):1348-54. PubMed ID: 391252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro antimicrobial activity of N-acetylcysteine against bacteria colonising central venous catheters.
    Mansouri MD; Darouiche RO
    Int J Antimicrob Agents; 2007 Apr; 29(4):474-6. PubMed ID: 17293092
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.